Safety and Efficacy of Luspatercept in Low-Risk Myelodysplastic Neoplasms with Anaemia

Background: Therapy of anaemia in people with low-risk Myelodysplastic Neoplasms (MDNs) is challenging. Luspatercept targets ineffective erythropoiesis. Objective: Define the safety and efficacy of luspatercept in people with low-risk MDNs and anaemia. Methods: A meta-analysis of prospective clinica...

Full description

Saved in:
Bibliographic Details
Published inBlood Vol. 144; no. Supplement 1; p. 6713
Main Authors Liang, Yang, Song, Yuanbin, Liu, Chenfei, Lu, Lu, Wu, Bingyi, Wang, Weida, Chen, Shuzhao, Chen, Lezong
Format Journal Article
LanguageEnglish
Published Elsevier Inc 05.11.2024
Online AccessGet full text

Cover

Loading…